Company Filing History:
Years Active: 1980-1982
Title: The Innovative Contributions of Bong K Lee
Introduction
Bong K Lee is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of microbiology and antibiotic development. With a total of 3 patents, his work has had a substantial impact on the medical community.
Latest Patents
One of his latest patents is the Macrolide antibiotic complex, known as the AR-5-3 Complex. This complex consists of four macrolide antibiotics elaborated by a mutant strain of Micromonospora polytrota. The antibiotics exhibit substantial activity against gram-positive bacteria both in vitro and in vivo. Another significant patent involves the microbiological methylation of aminoglycosyl-aminoglycosides. In this patent, the microorganisms Micromonospora inyoensis 1550F-1G and M. purpurea strain 1124 convert tobramycin, kanamycin A, kanamycin B, and dibekacin to their respective 3'-N-methyl and 3'-N-methyl-4'-C-methyl derivatives. These derivatives show significant activity against representative gram-positive and gram-negative bacteria and may also be converted to other derivatives with notable antibacterial activity.
Career Highlights
Bong K Lee has worked at Schering Corporation, where he has been able to apply his innovative ideas and research in a corporate setting. His work has contributed to advancements in antibiotic therapies, showcasing his expertise in microbiology and pharmacology.
Collaborations
Throughout his career, Bong K Lee has collaborated with notable colleagues such as Joseph A Marquez and Gerald H Wagman. These collaborations have further enhanced his research and development efforts in the field of antibiotics.
Conclusion
Bong K Lee's contributions to antibiotic development and microbiology are commendable. His innovative patents and collaborations reflect his dedication to advancing medical science. His work continues to influence the field and improve healthcare outcomes.